| Gene symbol | CCR5 | Synonyms | CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22 | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3p21.31 | dbXrefs | |
| Gene perturbation-related omics dataset | PertOrg | ||||
| Description | C-C motif chemokine receptor 5 | ||||
| GTO ID | GTC1891 |
| Trial ID | NCT03517631 |
| Disease | HIV Infection |
| Altered gene | CCR5 |
| Therapeutic/Target gene | Target gene |
| Therapy | shRNA |
| Treatment | shRNA-modified CD34+ cells |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | A Pilot Study to Evaluate Efficacy and Safety of Multiplexed shRNA-modified CD34+ Cells in HIV-infected Patients. |
| Year | 2018 |
| Country | China |
| Company sponsor | Shanghai Public Health Clinical Center |
| Other ID(s) | KL1702 |
| Vector information | |||||
|
|||||
| Cohort1: No busulfan preconditioning | |||||||
|
|||||||
| Cohort2: Low dose busulfan preconditioning | |||||||
|
|||||||
| Cohort3: High dose busulfan preconditioning | |||||||
|
|||||||